Advance Live Sessions Jan 5 - 8keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Advance Live Sessions Jan 5 - 8 - PST/PDT (Pacific Daylight, GMT-7)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
Advance Live Sessions Jan 5 - 8 - PST/PDT (Pacific Daylight, GMT-7)
search
Streams
Formats
8:30am - 9:00am30 mins
January 5 LIVE
ADVANCE LIVE SESSION - In conversation with the COVID-19 leaders: The COVID-19 therapeutic pivot — opportunities and challenges
8:30am - 9:00am30 mins
January 6 LIVE
ADVANCE LIVE SESSION - In conversation with the COVID-19 leaders: In the balance — the humanitarian perspective - global policy
- Jeremy A. Abbate - VP and Publisher, Scientific American Inc.
- Amy Finan - CEO, Sabin Vaccine Institute
- Richard Hachett - CEO, CEPI
8:30am - 9:00am30 mins
January 7 LIVE
ADVANCE LIVE SESSION - In conversation with the COVID-19 leaders: Accelerating treatments — the balancing act of safety and necessity
8:30am - 9:00am30 mins
January 8 LIVE
ADVANCE LIVE SESSION - In conversation with the COVID-19 leaders: The UK Perspective
10:00am - 11:00am60 mins
January 5 LIVE
ADVANCE LIVE SESSION - The world according to COVID-19: From crisis to long-term impact
- Michelle McMurry-Heath - President and CEO, Biotechnology Innovation Organization (BIO)
- Moncef Slaoui - Scientific Head, Operation Warp Speed
10:00am - 11:00am60 mins
January 6 LIVE
ADVANCE LIVE SESSION - Post-election policy and drug development: now what?
- Alice Valder Curran - Partner, Hogan Lovells
- Julie Gerberding - Executive VP and Chief Patient Officer, Merck & Co. Inc.
- Peter Kolchinsky - Founder and Managing Partner, RA Capital Management
- Jeremy Levin - Chairman and CEO, Ovid Therapeutics
- Greg Simon - Consultant, Simonovation LLC
10:00am - 11:00am60 mins
January 7 LIVE
ADVANCE LIVE SESSION - The pharma perspective: The unintended positive consequences of COVID-19
- Sam Fazeli - Director of EMEA Research and Senior Pharmaceutical Analyst, BI, Bloomberg L.P.
- Marianne De Backer - Head of Business Development & Licensing, Pharmaceutical Division, Bayer
- Shaun Grady - Senior VP of Business Development Operations, AstraZeneca
- Philippe Lopes-Fernandes - Executive VP and CBO, Ipsen
- John McDonald - Corporate VP and Global Head Business Development, Novo Nordisk
10:00am - 11:00am60 mins
January 8 LIVE
ADVANCE LIVE SESSION - Value creation: The cross-over investor and venture
- Eric Aguiar - Partner, Aisling Capital LLC
- Marian T. Nakada - VP Venture Investments, Johnson & Johnson Innovation, JJDC
12:00pm - 12:45pm45 mins
January 5 LIVE
ADVANCE LIVE SESSION - The pursuit for an effective vaccine developed at a pandemic pace
- Yasmeen Rahimi - Senior Research Analyst, Piper Sandler
- Sean Marett - CBO and CCO, BioNtech (NASDAQ: BNTX)
- Joseph E. Payne - President and CEO, Arcturus Therapeutics
- Scot Roberts - CSO, Altimmune (NASDAQ: ALT)
12:00pm - 12:30pm30 mins
January 6 LIVE
ADVANCE LIVE SESSION - In conversation with the COVID-19 leaders: The path forward
12:00pm - 12:45pm45 mins
January 7 LIVE
ADVANCE LIVE SESSION - The year of the IPO and the coming of age of the SPACs
- William Kolb - Partner, Foley Hoag
- Gabriel P. Cavazos - Managing Director, Investment Banking, SVB Leerink
- Paul J. Hastings - President and CEO, Nkarta Therapeutics, Inc. (NASDAQ GS: NKTX)
- Art Pappas - Managing Partner, Pappas Capital
- Scott Platshon - Principal, EcoR1 Capital
12:00pm - 12:45pm45 mins
January 8 LIVE
ADVANCE LIVE SESSION - The Investors' View: Where is the money going in 2021?
- Dennis J. Purcell - Founder and Senior Advisor, Aisling Capital
- Nina Kjellson - General Partner, Canaan
- Bibhash Mukhopadhyay - Principal, New Enterprise Associates (NEA)
- Camille Samuels - Partner, Venrock
Filter
Streams
Formats